Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Recipharm

Recipharm
1995 FOUNDED
PUBLIC STATUS
5K-10K EMPLOYEES
RECI B STOCK SYMBOL
28 INVESTMENTS
$15.18 SHARE PRICE (As of Tuesday Closing)
Description

Recipharm AB is a global biotechnology company that develops pharmaceutical drugs and technologies. The company operates in two core areas that include development and technology, and manufacturing. Recipharm's largest business stream is its manufacturing operation, which focuses on delivering a large number of pharmaceuticals in a variety of dosage forms. This segment also provides packaging services for customers. The company's overall business model focuses on uniting licensed development and manufacturing companies.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
STO
Primary Office
  • Box 603
  • 101 32 Stockholm
  • Sweden

+46 0000000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Recipharm’s full profile, request a free trial.

Recipharm Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$11.29 - $16.48 $1.03B $15.24 $0.33 182K 67.8M

Recipharm Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 1,344,914 1,207,578 1,191,070 1,097,531
Revenue 770,259 727,993 619,219 541,563
EBITDA 114,645 112,102 60,374 82,941
Net Income 22,918 18,320 (19,949) 22,022
Total Assets 1,384,822 1,414,645 1,432,941 1,079,378
Total Debt 488,702 496,932 511,527 284,349
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Recipharm Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Recipharm‘s full profile, request access.

Request full access to PitchBook

Recipharm Competitors (24)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Corden Pharma Venture Capital-Backed Plankstadt, Germany 0000 00000 00000
000 0000000 Corporate Backed or Acquired Riverview, MI 00 000000&0
00000000 000000000 Corporation Gaithersburg, MD 0000 000.00 000000000 000.00
00. 00000'0 000000 Corporation Hyderabad, India 00000 00000 000000 - 000 00000
0000000000 0000000 Private Equity-Backed Sarasota, FL 00 000000000000
To view this company’s complete list of competitors, request access »

Recipharm Investments & Acquisitions (28)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000 18-Nov-2019 000000000000000000 00000 Drug Delivery
0000000 000000 24-Apr-2019 00000 00000 00 00.000 Drug Discovery 0000-00000 0000 00.0
000000 (0000000000 01-Oct-2018 000000000000000000 000.00 Pharmaceuticals
00000 000000000000 01-Jun-2018 000000000 00000000 000.00 Pharmaceuticals
Sanofi (manufacturing center) 13-Jan-2018 Corporate Asset Purchase 000.00 Buildings and Property
To view this company’s complete investment and acquisition history, request access »

Recipharm Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 02-Oct-2015 00000 00000 00 00.000 Completed
  • 2 buyers
000000 29-Sep-2015 0000000000 Completed
  • 2 buyers
Cobra Biologics 01-Jan-2009 Merger/Acquisition Completed
To view this company’s complete exits history, request access »

Recipharm Subsidiaries (3)

Company Name Industry Location Founded
OnTarget Chemistry Other Commercial Services Uppsala, Sweden 2008
00000 000000000000 Pharmaceuticals Karnal, India 0000
00000 000000000 Biotechnology Keele, United Kingdom 0000
To view this company’s complete subsidiary history, request access »

Recipharm Executive Team (9)

Name Title Board
Seat
Contact
Info
Kjell Johansson President, Manufacturing Services Europe & Chief Operating Officer
Tobias Hägglöv Chief Financial Officer
Anke Mollowitz Key Account Director
Mark Quick Executive Vice President, Corporate Development
Carl-Johan Spak Ph.D Executive Vice President, Global Technologies

3 Former Executives

You’re viewing 5 of 9 executives. Get the full list »